Premier Biomedical, Inc. (OTCQB: "BIEI") announced the addition of Dr. Carl E. Meyer and his wife, Dr. Kathryn R. Meyer to their Scientific Advisory Board effective immediately. Dr. & Dr. Meyer will report to the co-founder and Chairman of the Scientific Advisory Board, Dr. Mitchell S. Felder, MD, and to the President and CEO, William A. Hartman.
Carl E. Meyer, DO, MBA, is a pediatrician and a Fellow of the American Academy of Pediatrics. He has been a practicing pediatrician for 35 years, initially in solo practice in Greenville, PA, and currently with Hope Pediatrics in Seneca, PA. He received his undergraduate degree from Florida Atlantic University in Boca Raton, and his Doctor of Osteopathic Medicine from the Philadelphia College of Osteopathic Medicine.
Dr. Carl Meyer spent many years on staff at University of Pennsylvania Medical Center (UPMC) Horizon as a general pediatrician, Chair of the Department of Pediatrics, and President of the Medical Staff. He also served as Medical Director of Quality and Risk Management for three years, earning his MBA from Alvernia College in Reading, PA to enhance his work in Medical Quality. As a pediatrician, Dr. Carl Meyer has participated in over 75 clinical research studies in childhood immunizations, and has authored a book on child care and contributed material for books and newspapers. He has been a clinical instructor for several medical schools and physician assistant programs for many years.
Kathryn Meyer, DO, is an Emergency Physician, certified by the American Academy of Osteopathic Emergency Physicians. She received her undergraduate degree from Penn State University and her Doctor of Osteopathic Medicine from the Philadelphia College of Osteopathic Medicine. She is currently Medical Director of the University of Pennsylvania Medical Center (UPMC) Hermitage Urgent Care Center in Hermitage, PA. Prior to that, she practiced Emergency Medicine at UPMC Horizon for 30 years.
During her career, Dr. Kathryn Meyer has been the Medical Director of local ambulance companies. She served as Assistant Medical Director of Emergency Medicine for UPMC Horizon for 15 years and was appointed to Medical Staff committees for Medical Care and Risk Management. She has been an instructor for Advance Cardiac Life Support program for many years.
William A. Hartman, President and CEO of Premier Biomedical stated, "I have known Dr. Carl Meyer and Dr. Kathryn Meyer for a number of years and am pleased they have agreed to join our outstanding Scientific Advisory Board. Together, they bring new perspectives to our medical research and development efforts, not only in the area of pediatric medicine, and quality and risk management, but also in the area of emergency medicine.”
About Premier Biomedical, Inc.
Premier Biomedical, Inc. is a research-based company that intends to discover and develop medical treatments for a wide range of diseases in humans, initially targeting the treatment of cancer. The Company's common stock trades on the Over-The-Counter Bulletin Board under the ticker symbol "BIEI." http://www.premierbiomedicalinc.com/
Safe Harbor Notice
Statements made in this news release constitute forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995. Premier Biomedical makes no guarantee of future performance and actual results could differ materially. Premier Biomedical, Inc. undertakes no obligation to revise or update these.
View source version on businesswire.com: http://www.businesswire.com/news/home/20150825005559/en/